Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Moderna Inc shares valued at $4,849 were sold by Klinger Shannon Thyme on Dec 03 ’24. At $43.30 per share, Klinger Shannon Thyme sold 112 shares. The insider’s holdings dropped to 19,837 shares worth approximately $0.83 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Hoge Stephen sold 314 shares, netting a total of over 13,595 in proceeds. Following the sale of shares at $43.30 each, the insider now holds 1,443,904 shares.
Before that, Klinger Shannon Thyme had added 112 shares to its account. In a trade valued at $4,849, the Officer bought Moderna Inc shares for $43.30 each.
As published in their initiating research note from Berenberg on November 19, 2024, Moderna Inc [MRNA] has been a Hold and the price target has been revised to $42. Analysts at HSBC Securities upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in mid November. As of November 15, 2024, Wolfe Research has initiated its “an Underperform” rating for MRNA. Earlier on October 17, 2024, Bernstein initiated its rating. Their recommendation was “a Mkt perform” for MRNA stock.
Analyzing MRNA Stock Performance
During the last five days, there has been a drop of approximately -1.00%. Over the course of the year, Moderna Inc shares have dropped approximately -58.14%. Shares of the company reached a 52-week high of $170.47 on 05/24/24 and a 52-week low of $35.80 on 11/15/24. A 50-day SMA is recorded $51.51, while a 200-day SMA reached $94.54. Nevertheless, trading volume fell to 5.0 million shares from 7.25 million shares the previous day.
Support And Resistance Levels for Moderna Inc (MRNA)
According to the 24-hour chart, there is a support level at 41.14, which, if violated, would cause prices to drop to 40.65. In the upper region, resistance lies at 42.46. The next price resistance is at 43.29. RSI (Relative Strength Index) is 39.78 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 2.08, which suggests the price will increase in the coming days. Percent R is at 44.48%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
